Pastillation: A novel technology for development of oral lipid based multiparticulate controlled release formulation

Powder Technology

Volumn 209, Issue 1-3, 2011, Pages 65-72

  Shukla, Dali ^a   Chakraborty, Subhashis ^a   Singh, Sanjay ^a   Mishra, Brahmeshwar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Controlled release; Doxofylline; Lipid; Pastillation; Pastilles; Stearic acid

Indexed keywords

CONTROLLED RELEASE; CONTROLLED RELEASE FORMULATIONS; DOSAGE FORMS; DOXOFYLLINE; DRUG CONTENT; DRUG RELEASE; FLOW PROPERTIES; LABORATORY-SCALE DEVICES; LARGE SCALE EQUIPMENTS; LINE EXTENSION; MELT EXTRUSION; NOVEL TECHNIQUES; OPTIMIZED CONDITIONS; PARTICULATE SYSTEMS; PASTILLATION; PASTILLES; PHARMACEUTICAL FIELDS; PLATE TEMPERATURE; SIMPLE METHOD; UNIFORM SIZE;

CHEMICAL EQUIPMENT; CHEMICAL INDUSTRY; CONTACT ANGLE; DRUG DELIVERY; DRUG DOSAGE; PELLETIZING; STEARIC ACID;

DRUG PRODUCTS;

DOXOFYLLINE; LIPID; STEARIC ACID;

ARTICLE; CONTACT ANGLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG MANUFACTURE; DRUG STABILITY; FREEZE PELLETIZATION; MELT EXTRUSION; PARTICLE SIZE; PASTILLATION; PASTILLE; PROCESS OPTIMIZATION; SUSTAINED DRUG RELEASE; TEMPERATURE; WEIGHT;

EID: 79953025332     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2011.02.006     Document Type: Article

References (17)

1. Remington: The Science and Practice of Pharmacy 2000, Lippincott, Williams & Wilkins, USA. 20th ed. A.R. Gennaro (Ed.).
2. Bussemer T., Otto I., Bodmeier R. Pulsatile drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 2001, 18:433-458.
3. Das N.G., Das S.K. Controlled release of oral dosage forms. Formulation, Fill and Finish 2003, 10-16. http://www.pharmtech.com.
4. Bechgaard H., Nielsen G.H. Controlled-release multiple-units and single-unit doses - a literature review. Drug Dev. Ind. Pharm. 1978, 4:53-67.
5. Ito Y., Arai H., Uchino K., Iwasaki K., Shibata N., Takada K. Effect of adsorbents on the absorption of lansoprazole with surfactant. Int. J. Pharm. 2005, 289:69-77.
6. Schaefer T., Holm P., Kristensen H.G. Melt granulation in a laboratory scale high shear mixer. Drug Dev. Ind. Pharm. 1990, 16:1249-1277.
7. White J.L., Szdlowski W., Min K., Kim M.H. Twin screw extruders: development of technology analysis of flow. Adv. Polym. Technol. 1987, 7:295-332.
8. Kim J.W., Ulrich J. Prediction of degree of deformation and crystallization time of molten droplets in pastillation process. Int. J. Pharm. 2003, 257:205-215.
9. Adeyeye C.M., Price J.C. Development and evaluation of sustained release ibuprofen-wax microspheres. I. Effect of formulation variables on physical characteristics. Pharm. Res. 1991, 8:1377-1383.
10. Paradkar A.R., Maheshwari M., Ketkar A.R., Chauhan B. Preparation and evaluation of ibuprofen beads by melt solidification technique. Int. J. Pharm. 2003, 255:33-42.
11. http://www.processsystems.sandvik.com/.
12. Chakraborty S., Shukla D., Mishra B., Singh S. Lipid - an emerging platform for oral delivery of drugs with poor bioavailability. Eur. J. Pharm. Biopharm. 2009, 73:1-15.
13. Shukla D., Chakraborty S., Singh S., Mishra B. Lipid based oral multiparticulate formulations - advantages, technological advances and industrial applications. Expert Opin. Drug Deliv. 2011, 8:207-224.
14. Gutowski W. Thermodynamics of adhesion. Fundamentals of adhesion 1991, 87-136. Plenum Publishing Corporation, New York. L.-H. Lee (Ed.).
15. Mahalingam R., Li X., Jasti B.R. Semisolid dosages: ointments, creams and gels. Pharmaceutical Manufacturing Handbook: Production and Processes 2008, 267-312. John Wiley and Sons, Inc, New Jersey. S.C. Gad (Ed.).
16. Tarrago-Trani M.T., Phillips K.M., Lemar L.E., Holden J.M. New and existing oils and fats used in products with reduced trans-fatty acid content. J. Am. Diet. Assoc. 2006, 106:867-880.
17. Shukla D., Chakraborty S., Singh S., Mishra B. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opin. Pharmacother. 2009, 10:2343-2356.